BWAM
Boyd Watterson Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $508K | Buy |
967
+77
| +9% | +$40.4K | 0.16% | 93 |
|
|
2025
Q1 | $564K | Sell |
890
-15
| -2% | -$9.51K | 0.18% | 91 |
|
|
2024
Q4 | $645K | Sell |
905
-286
| -24% | -$204K | 0.18% | 81 |
|
|
2024
Q3 | $1.25M | Sell |
1,191
-4
| -0.3% | -$4.21K | 0.34% | 62 |
|
|
2024
Q2 | $1.26M | Hold |
1,195
| – | – | 0.36% | 57 |
|
|
2024
Q1 | $1.15M | Buy |
1,195
+276
| +30% | +$266K | 0.41% | 54 |
|
|
2023
Q4 | $807K | Sell |
919
-17
| -2% | -$14.9K | 0.32% | 63 |
|
|
2023
Q3 | $770K | Sell |
936
-11
| -1% | -$9.05K | 0.34% | 62 |
|
|
2023
Q2 | $680K | Hold |
947
| – | – | 0.27% | 75 |
|
|
2023
Q1 | $778K | Sell |
947
-13
| -1% | -$10.7K | 0.32% | 73 |
|
|
2022
Q4 | $693K | Buy |
960
+9
| +0.9% | +$6.49K | 0.29% | 81 |
|
|
2022
Q3 | $655K | Sell |
951
-15
| -2% | -$10.3K | 0.3% | 79 |
|
|
2022
Q2 | $571K | Sell |
966
-6
| -0.6% | -$3.55K | 0.24% | 87 |
|
|
2022
Q1 | $679K | Buy |
972
+20
| +2% | +$14K | 0.25% | 93 |
|
|
2021
Q4 | $601K | Hold |
952
| – | – | 0.2% | 98 |
|
|
2021
Q3 | $576K | Buy |
952
+143
| +18% | +$86.5K | 0.21% | 100 |
|
|
2021
Q2 | $452K | Sell |
809
-1,443
| -64% | -$806K | 0.18% | 111 |
|
|
2021
Q1 | $1.07M | Buy |
2,252
+488
| +28% | +$231K | 0.47% | 68 |
|
|
2020
Q4 | $852K | Buy |
+1,764
| New | +$852K | 0.41% | 74 |
|